Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 96901-96950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04781270
mFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases
PHASE3Recruiting
308 participants
Started: Apr 15, 2021 · Completed: Mar 30, 2026
2 conditions1 sponsor1 location
NCT04996342
A Cohort Study of Chronic Cardiovascular Diseases
N/ARecruiting
10,000 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04812002
Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
PHASE2Recruiting
20 participants
Started: Apr 15, 2021 · Completed: Apr 15, 2026
1 condition1 sponsor1 location
NCT04822649
Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition
NARecruiting
100 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04534972
Strategy to Avoid Excessive Oxygen in Major Burn Patients
PHASE3Active, not recruiting
2,000 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2025
4 conditions2 sponsors6 locations
NCT04965259
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
N/AActive, not recruiting
2,002 participants
Started: Apr 15, 2021 · Completed: Dec 21, 2026
1 condition7 sponsors14 locations
NCT04898335
Tendyne European Experience Registry
N/ARecruiting
400 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor30 locations
NCT05056844
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge
NARecruiting
66 participants
Started: Apr 15, 2021 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT04580420
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
PHASE2Recruiting
28 participants
Started: Apr 15, 2021 · Completed: Jan 30, 2032
2 conditions1 sponsor18 locations
NCT04690322
POCUS: Hemostatic Potential and Joint Health in Patients With Severe Hemophilia A on Novel Replacement Therapies
PHASE4Recruiting
28 participants
Started: Apr 15, 2021 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT04912765
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
PHASE2Recruiting
60 participants
Started: Apr 15, 2021 · Completed: Jun 30, 2027
5 conditions2 sponsors1 location
NCT04672265
Increasing Access to Breast Cancer Screening Among Immigrants
NAActive, not recruiting
11,355 participants
Started: Apr 15, 2021 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT04732156
Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System
NARecruiting
420 participants
Started: Apr 14, 2021 · Completed: Jun 15, 2026
1 condition1 sponsor17 locations
NCT04270175
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
PHASE2Active, not recruiting
15 participants
Started: Apr 14, 2021 · Completed: Sep 30, 2027
3 conditions2 sponsors4 locations
NCT04794699
Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion
PHASE1Recruiting
180 participants
Started: Apr 14, 2021 · Completed: Mar 30, 2027
1 condition1 sponsor38 locations
NCT05969951
VTE Risk Prevention System Based on Big Data Analysis and Multimodule System
N/ARecruiting
100,000 participants
Started: Apr 14, 2021 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT04875351
Breast Cancer Index (BCI) Registry
N/AActive, not recruiting
3,465 participants
Started: Apr 14, 2021 · Completed: Dec 31, 2028
1 condition1 sponsor105 locations
NCT04736706
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
PHASE3Active, not recruiting
1,653 participants
Started: Apr 14, 2021 · Completed: Oct 29, 2026
1 condition2 sponsors262 locations
NCT04167033
Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QT-IOP)
NARecruiting
120 participants
Started: Apr 14, 2021 · Completed: Apr 13, 2024
1 condition1 sponsor3 locations
NCT04620759
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
PHASE2Recruiting
90 participants
Started: Apr 14, 2021 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT04775355
Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer
N/ARecruiting
30 participants
Started: Apr 14, 2021 · Completed: Jul 29, 2026
6 conditions2 sponsors1 location
NCT04514250
Stress Aortic Valve Index for Assessing Risk in Aortic Valve Stenosis Patients
N/AActive, not recruiting
52 participants
Started: Apr 14, 2021 · Completed: Oct 1, 2028
1 condition1 sponsor5 locations
NCT04885322
Effects of PFC tDCS on Cognitive Control, Attention Lapses and Coordinated Neural Activity in the Theta and Alpha Bands
NARecruiting
75 participants
Started: Apr 14, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT04795635
Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management
NAActive, not recruiting
61 participants
Started: Apr 14, 2021 · Completed: Aug 22, 2024
2 conditions1 sponsor3 locations
NCT04745728
Different Immunosuppressive Treatment in iMN
PHASE3Recruiting
200 participants
Started: Apr 14, 2021 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT05417867
Evaluating the Association Between Changes in the Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast Cancer
N/ARecruiting
70 participants
Started: Apr 14, 2021 · Completed: Mar 31, 2026
4 conditions1 sponsor5 locations
NCT04794972
A Study of GNC-039, a Tetra-specific Antibody, in Participants With Relapsed/Refractory or Metastatic Solid Tumors
PHASE1Recruiting
60 participants
Started: Apr 14, 2021 · Completed: Dec 31, 2026
2 conditions2 sponsors6 locations
NCT04843904
Safe Accelerated Venetoclax Escalation in CLL
PHASE1Active, not recruiting
40 participants
Started: Apr 14, 2021 · Completed: Jun 2, 2030
2 conditions1 sponsor1 location
NCT04683003
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
PHASE3Recruiting
77 participants
Started: Apr 14, 2021 · Completed: Mar 16, 2027
1 condition3 sponsors27 locations
NCT06311344
Filling Key Research Gaps With Clinical Implications in Mansonellosis and Schistosomiasis: a Network Approach
NARecruiting
200 participants
Started: Apr 14, 2021 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT04216316
Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer
PHASE1/PHASE2Active, not recruiting
12 participants
Started: Apr 14, 2021 · Completed: Apr 12, 2025
2 conditions1 sponsor34 locations
NCT04382963
Stroke Prevention in the Wisconsin Native American Population
NAActive, not recruiting
120 participants
Started: Apr 14, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT04844177
Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia
PHASE2Not yet recruiting
10 participants
Started: Apr 14, 2021 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT04923958
Rapid Research in Diagnostics Development for TB Network
NARecruiting
26,436 participants
Started: Apr 14, 2021 · Completed: Dec 31, 2031
1 condition20 sponsors16 locations
NCT04594603
Changes of Macular Vasculature After Uncomplicated Phacoemulsification Surgery Using Optical Coherence Tomography Angiography
N/ARecruiting
30 participants
Started: Apr 13, 2021 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT04763200
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function
NAActive, not recruiting
1,252 participants
Started: Apr 13, 2021 · Completed: Oct 31, 2027
2 conditions1 sponsor102 locations
NCT04225507
Technology-Supported Treatment of Sleep Apnea in Prediabetes
NARecruiting
174 participants
Started: Apr 13, 2021 · Completed: Jul 31, 2026
3 conditions3 sponsors1 location
NCT04475783
Sirolimus- vs. Paclitaxel-Drug Coated Ballons in Patients With Peripheral Artery Disease
NAActive, not recruiting
478 participants
Started: Apr 13, 2021 · Completed: Dec 31, 2027
1 condition5 sponsors26 locations
NCT04843436
PRIMO Post-Market Clinical Follow Up Study
NAActive, not recruiting
429 participants
Started: Apr 13, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor10 locations
NCT04103476
Advancing Postmenopausal Preventive Therapy
PHASE2Active, not recruiting
385 participants
Started: Apr 13, 2021 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05346185
Lung Cancer Surgery in Sarcopenia Patients With Old Age
N/ARecruiting
400 participants
Started: Apr 13, 2021 · Completed: Jun 30, 2028
2 conditions1 sponsor1 location
NCT04860765
COMPASSION S3 Post-Approval Study
N/AActive, not recruiting
150 participants
Started: Apr 13, 2021 · Completed: Aug 31, 2030
5 conditions1 sponsor19 locations
NCT04836936
Auriculotherapy in the Treatment of Pre-Operative Anxiety
NARecruiting
60 participants
Started: Apr 13, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT04402242
Impact of NOL Index Intraoperative Guided Remifentanil Analgesia
NARecruiting
210 participants
Started: Apr 13, 2021 · Completed: May 31, 2025
1 condition1 sponsor3 locations
NCT04836546
Eversense® Non-adjunctive Use Post Approval Study
NAActive, not recruiting
925 participants
Started: Apr 13, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor23 locations
NCT04601805
Optical Coherence Tomography Angiography Assessment of Retinal Lesions in Inflammatory Bowel Diseases
N/ARecruiting
30 participants
Started: Apr 13, 2021 · Completed: Dec 29, 2024
1 condition1 sponsor1 location
NCT06333249
A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)
PHASE2Active, not recruiting
14 participants
Started: Apr 13, 2021 · Completed: Feb 28, 2027
1 condition1 sponsor6 locations
NCT04668690
Clinical Study of Mitoxantrone Hydrochloride Liposome Injection vs. Chidamide in Patients With Relapsed/Refractory PTCL
PHASE3Active, not recruiting
193 participants
Started: Apr 13, 2021 · Completed: Dec 30, 2028
1 condition1 sponsor1 location
NCT04527380
A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
PHASE3Active, not recruiting
101 participants
Started: Apr 13, 2021 · Completed: Apr 30, 2028
2 conditions1 sponsor43 locations
NCT04768062
Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)
PHASE3Active, not recruiting
74 participants
Started: Apr 13, 2021 · Completed: Nov 30, 2025
1 condition2 sponsors31 locations